ATAchara Tongpoo

Achara Tongpoo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Achara Tongpoo has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Clinical Characteristics and Outcomes of Sea Snake Bites in Thailand: A Retrospective Study

    by Panee Rittilert, Satariya Trakulsrichai, Achara Tongpoo, Taksa Vasaruchapong, Phantakan Tansuwannarat

    Sea snake bites are uncommon but may cause severe myotoxic and neurotoxic envenoming. Contemporary clinical data from Thailand remain limited. Using a 15-year retrospective dataset from the Ramathibodi Poison Center, we described the clinical characteristics, treatment, and outcomes of sea snake bites reported between January 2011 and June 2026. Cases were classified as definite when the causative snake was identified from a specimen, photograph, or video, and as possible when identification was based on the patient’s or a witness’s account. Eight patients were included, with a median age of 42 years (range 6–65 years); seven were male, and seven were fishermen. Four cases were classified as definite and four as possible. Five bites occurred while handling fishing nets. Local manifestations were generally mild, with swelling absent in seven patients. Three patients developed rhabdomyolysis with myoglobinuria, with the highest recorded serum creatine kinase concentrations ranging from 39,189 to 239,287 U/L. Two patients developed severe neurotoxic envenoming characterised by ptosis and generalised limb weakness requiring invasive mechanical ventilation. Thai Neuro Polyvalent Antivenom was administered to one patient; however, its clinical effectiveness cannot be determined from this study. In another patient, ophthalmoplegia was first documented on day 6, with intermittent visual symptoms persisting to day 18. Despite marked rhabdomyolysis, no patient developed acute kidney injury. All patients survived. Sea snake bites in Thailand showed a broad clinical spectrum, ranging from mild local effects to severe myotoxic and neurotoxic envenoming. These findings highlight that minimal local manifestations do not exclude severe systemic toxicity and support close neurological assessment and serial monitoring for muscle injury following suspected sea snake bites.

  • Open Access

    Development and validation of a Ramathibodi Poison Center scoring system to predict follow-up necessity in hospitalized patients: a retrospective study

    by Kitisak Sanprasert, Satariya Trakulsrichai, Phantakan Tansuwannarat, Panee Rittilert, Achara Tongpoo

    The Ramathibodi Poison Center, one of Thailand’s two primary poison control centers, serves as a critical tertiary reference unit for toxicological management. As a tertiary reference unit, the cen...

  • Open Access

    Clinical Characteristics and Outcomes of Asian Coral Snake Bites in Thailand: A Retrospective Cohort Study

    by Phantakan Tansuwannarat, Satariya Trakulsrichai, Juthathip Pathumarak, Achara Tongpoo

    Asian coral snakes are distributed throughout Southeast Asia, including Thailand, but clinical data on their envenomation remain limited. Using a 10-year retrospective dataset from the Ramathibodi Poison Center, we investigated the epidemiology, clinical characteristics, management, and outcomes of Asian coral snake envenomation in Thailand. Patient demographics, clinical and laboratory data, treatments, and outcomes were analyzed descriptively. Fifty-two patients were included. Sinomicrurus macclellandi was the most frequently reported species. Most bites occurred during the rainy season and involved the lower extremities. Clinical manifestations were predominantly mild and localized. No cases of systemic neurotoxicity, bulbar weakness, respiratory compromise, or death were observed. Laboratory results were generally within normal limits. Two patients developed anaphylaxis, which resolved with standard emergency treatment, while two experienced severe pain. Calliophis intestinalis lineata was associated with a higher proportion of tachycardia at presentation and longer hospitalization. No patients required mechanical ventilation or antivenom therapy. Supportive care and short-term hospital observation are generally sufficient in confirmed cases. The median duration of hospitalization was 1–3 day. Local manifestations were the predominant clinical findings following Asian coral snake envenomation in Thailand, and systemic neurotoxicity was not observed. These findings differ from reports of Micrurus envenomation, which primarily involve New World coral snakes, whereas the species implicated in Thailand belong to Old World genera.


  • Open Access

    Trends and Patterns of Animal Poisoning in Thailand: A 10-Year Retrospective Study from Ramathibodi Poison Center

    by Phantakan Tansuwannarat, Satariya Trakulsrichai, Kitisak Sanprasert, Sekkarin Ploypetch, Nastayarin Ariyaviraplorn, Achara Tongpoo

    Animal poisoning remains an underreported public health and veterinary concern in many low- and middle-income countries where comprehensive surveillance systems are limited. This study was initiated to describe the epidemiology, clinical characteristics, and outcomes of animal poisoning cases reported to a national poison center in Thailand over a 10-year period. We performed a retrospective review of cases recorded in the Ramathibodi Poison Center Toxic Exposure Surveillance System between 2015 and 2024. Descriptive statistics were used to summarize species distribution, exposure categories, clinical signs, treatment, and outcomes, and comparisons were conducted to identify factors associated with mortality. A total of 118 poisoning cases were identified, with annual numbers increasing over time. Companion animals accounted for most exposures (93.2%), particularly dogs. Pesticides were the most common toxic agents, followed by household products, pharmaceuticals, and plant toxins. Neurological signs were the predominant clinical presentation. Respiratory compromise and neurological involvement at presentation were significantly associated with mortality. Overall survival was 88.1%. Fatalities were mainly linked to exposure to highly toxic pesticides or plants, including confirmed cassava-associated cyanide poisoning in elephants. This study highlights preventable environmental toxic risks affecting animals in Thailand and demonstrates the value of centralized poison surveillance. Strengthening pesticide safety practices and integrating veterinary toxicology into broader public health monitoring may reduce avoidable poisonings within shared human–animal environments.

  • Open Access

    Ethephon Poisoning: Clinical Characteristics and Outcomes

    by Satariya Trakulsrichai, Kanokrat Chuayaupakarn, Phantakan Tansuwannarat, Panee Rittilert, Achara Tongpoo, Charuwan Sriapha, Winai Wananukul

    Ethephon (2-chloroethylphosphonic acid) is a generally used plant growth regulator, but the data on its toxic effects, especially in humans, are very limited. This study was conducted to describe the clinical characteristics, management, and outcomes of patients exposed to products containing ethephon. We performed an 8-year retrospective study using data from the Ramathibodi Poison Center database (2013–2020), which included 252 patients. Most patients were male, with a median age of 32 years. Almost all patients were exposed through ingestion, mainly in unintentional circumstances. The clinical presentations included local effects, gastrointestinal (GI), neurological, and respiratory symptoms. Some patients required hospital admission; specifically, seven patients received inotropic drugs, and six were intubated with ventilator support. Most patients had either no or only minor clinical effects. However, six patients experienced moderate/severe effects, and two patients died. Age, intentional exposure, and the presence of initial neurological symptoms could prognosticate moderate to fatal outcomes. In conclusion, exposure to ethephon predominantly resulted in no or minor effects, and GI symptoms were the most common clinical manifestation. The cholinergic toxic syndrome was not frequently observed. The mortality rate was very low. Patients presenting with factors associated with worse outcomes should be monitored closely for clinical deterioration and appropriately managed.


  • Open Access

    Emamectin Poisoning in Thailand: Clinical Characteristics and Outcomes

    by Satariya Trakulsrichai, Perapatn Sittiyuno, Phantakan Tansuwannarat, Achara Tongpoo

    Emamectin benzoate (Emamectin) is a broad-spectrum insecticide. Current data regarding emamectin poisoning in humans are very limited. We performed a 10-year retrospective cross-sectional study (2011–2020) using data from the Ramathibodi Poison Center database to examine the clinical characteristics and outcomes in patients exposed to emamectin. Eighty-eight patients were included. Most of the patients were male (72.7%) and exposure was frequently oral (86.4%) and intentional (67.0%).Their mean age was 42.8 years. The clinical presentations included gastrointestinal tract symptoms (62.5%), neurological symptoms (27.3%) including seizures, respiratory symptoms (6.8%), and local effects (12.5%). At presentation, the majority of patients exhibited normal consciousness and vital signs. Eleven patients showed no obvious clinical effects. Initially, 15 patients had metabolic acidosis and 11 had hypokalemia. Overall, 46 and 52 patients were administered gastric lavage and activated charcoal, respectively. Most patients (78.4%) were hospitalized, with a median hospital stay of 40 h, and generally received supportive treatment. Eight patients were intubated for ventilator support and one received inotropic drugs. Most patients (90.9%) showed no or minor outcomes; however, two patients died. The presence of Glasgow Coma Scale (GCS) p < 0.001) between patients with no or minor outcomes (n = 80) and those with moderate or fatal outcomes (n = 8). In conclusion, emamectin poisoning mainly caused no or minor clinical effects. A low GCS at presentation was associated with worse outcomes. Therefore, patients who present with low GCS should be closely observed, monitored, and properly managed during hospitalization.


  • Open Access

    A 10-Year Retrospective Analysis of Medication Errors among Adult Patients: Characteristics and Outcomes

    by Phantakan Tansuwannarat, Piraya Vichiensanth, Ornlatcha Sivarak, Achara Tongpoo, Puangpak Promrungsri, Charuwan Sriapha, Winai Wananukul, Satariya Trakulsrichai

    Medication errors (MEs) are a global health problem. We conducted this study to clarify the clinical characteristics, outcomes, and factors associated with MEs that caused harm to adult patients (>15 years of age) who were managed in hospitals or healthcare facilities. We performed a 10-year retrospective study (2011–2020) by analyzing data from the Ramathibodi Poison Center (RPC) database (RPC Toxic Exposure Surveillance System). There were a total of 112 patients included in this study. Most were women (59.8%) and had underlying diseases (53.6%). The mean patient age was 50.5 years. Most MEs occurred during the afternoon shift (51.8%) and in the outpatient department (65.2%). The most common type of ME was a dose error (40.2%). Local anesthetic was the most common class of ME-related drug. Five patients died due to MEs. We analyzed the factors associated with MEs that caused patient harm, including death (categories E–I). The presence of underlying diseases was the single factor that was statistically significantly different between groups. Clinical characteristics showed no significant difference between patients aged 15–65 years and those aged >65 years. In conclusion, our findings emphasized that MEs can cause harm and even death in some adult patients. Local anesthetics were the most commonly involved in MEs. Having an underlying disease might contribute to severe consequences from MEs. Preventive measures and safety systems must be highlighted and applied to prevent or minimize the occurrence of MEs.


  • Open Access

    A Retrospective Cohort Study of Cobra Envenomation: Clinical Characteristics, Treatments, and Outcomes

    by Phantakan Tansuwannarat, Achara Tongpoo, Suraphong Phongsawad, Charuwan Sriapha, Winai Wananukul, Satariya Trakulsrichai

    This study investigated the clinical characteristics, treatments, and outcomes of envenomation involving cobra species in Thailand (Naja kaouthia, Naja siamensis, and Naja sumatrana). Data of patients who had been bitten by a cobra or inoculated via the eyes/skin in 2018–2021 were obtained from the Ramathibodi Poison Center. There were 1045 patients admitted during the 4-year study period (bite, n = 539; ocular/dermal inoculation, n = 506). Almost all patients with ocular/dermal inoculation had eye involvement and ocular injuries, but none had neurological effects. Most of the patients bitten by a cobra had local effects (69.0%) and neurological signs and symptoms (55.7%). The median interval between the bite and the onset of neurological symptoms was 1 h (range, 10 min to 24 h). Accordingly, patients should be observed closely in hospitals for at least 24 h after a bite. Intubation with ventilator support was required in 45.5% of patients and for a median duration of 1.1 days. Antivenom was administered in 63.5% of cases. There were nine deaths, most of which resulted from severe infection. Neurological effects and intubation were significantly more common after a monocled cobra bite than after a spitting cobra bite. The administration of antivenom with good supportive care, including the appropriate management of complications, especially wound infection, might decrease fatality.